cagrisema semaglutide cagrilintide phase 3 results 2024 2025 combination Incretin-based therapies for the treatment of obesity-related diseases Three new phase 3 REIMAGINE – Novo Nordisk stock crashes after

US$ 29.27

★★★★★ 4.6 (17 reviews)

US$ 25.77

★★★★★ 4.0 (11 reviews)

US$ 26.91

★★★★★ 4.0 (9 reviews)

US$ 21.57

★★★★★ 4.6 (20 reviews)

US$ 20.15

★★★★★ 4.7 (16 reviews)

US$ 21.98

★★★★★ 4.1 (29 reviews)

US$ 29.31

★★★★★ 4.6 (13 reviews)

US$ 20.36

★★★★★ 4.5 (11 reviews)

US$ 29.14

★★★★★ 5.0 (21 reviews)

US$ 28.45

★★★★★ 4.8 (9 reviews)

US$ 25.26

★★★★★ 4.9 (10 reviews)

US$ 22.85

★★★★★ 5.0 (7 reviews)

US$ 21.96

★★★★★ 4.2 (10 reviews)

US$ 20.12

★★★★★ 4.1 (7 reviews)

US$ 24.26

★★★★★ 4.3 (17 reviews)

US$ 20.58

★★★★★ 4.6 (29 reviews)

US$ 26.55

★★★★★ 4.9 (30 reviews)

US$ 28.22

★★★★★ 4.1 (29 reviews)

US$ 22.79

★★★★★ 4.6 (11 reviews)

US$ 29.72

★★★★★ 4.7 (19 reviews)